APA

Cochrane S. A., Salt L. J., Wantling E., Rogers A., Coutts J., Ballmer-Weber B. K., Fritsche P., Fernández-Rivas M., Reig I., Knulst A., Le T., Asero R., Beyer K., Golding M., Crevel R., Clare Mills E. N. & Mackie A. R. (20120328). Development of a standardized low-dose double-blind placebo-controlled challenge vehicle for the EuroPrevall project. : Allergy.

Chicago

Cochrane S A, Salt L J, Wantling E, Rogers A, Coutts J, Ballmer-Weber B K, Fritsche P, Fernández-Rivas M, Reig I, Knulst A, Le T-M, Asero R, Beyer K, Golding M, Crevel R, Clare Mills E N and Mackie A R. 20120328. Development of a standardized low-dose double-blind placebo-controlled challenge vehicle for the EuroPrevall project. : Allergy.

Harvard

Cochrane S. A., Salt L. J., Wantling E., Rogers A., Coutts J., Ballmer-Weber B. K., Fritsche P., Fernández-Rivas M., Reig I., Knulst A., Le T., Asero R., Beyer K., Golding M., Crevel R., Clare Mills E. N. and Mackie A. R. (20120328). Development of a standardized low-dose double-blind placebo-controlled challenge vehicle for the EuroPrevall project. : Allergy.

MLA

Cochrane S A, Salt L J, Wantling E, Rogers A, Coutts J, Ballmer-Weber B K, Fritsche P, Fernández-Rivas M, Reig I, Knulst A, Le T-M, Asero R, Beyer K, Golding M, Crevel R, Clare Mills E N and Mackie A R. Development of a standardized low-dose double-blind placebo-controlled challenge vehicle for the EuroPrevall project. : Allergy. 20120328.